{"organizations": [], "uuid": "280bd830afb1a922dd875797afd4f4cf1c37ad5c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180223.html", "section_title": "Archive News &amp; Video for Friday, 23 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-iridex-issues-voluntary-recall-of/brief-iridex-issues-voluntary-recall-of-trufocus-lio-premiere-laser-indirect-ophthalmoscope-idUSFWN1QD1GS", "country": "US", "domain_rank": 408, "title": "BRIEF-Iridex Issues Voluntary Recall Of Trufocus Lio Premiere Laser Indirect Ophthalmoscope", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.164, "site_type": "news", "published": "2018-02-24T05:11:00.000+02:00", "replies_count": 0, "uuid": "280bd830afb1a922dd875797afd4f4cf1c37ad5c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-iridex-issues-voluntary-recall-of/brief-iridex-issues-voluntary-recall-of-trufocus-lio-premiere-laser-indirect-ophthalmoscope-idUSFWN1QD1GS", "ord_in_thread": 0, "title": "BRIEF-Iridex Issues Voluntary Recall Of Trufocus Lio Premiere Laser Indirect Ophthalmoscope", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "iridex corp", "sentiment": "negative"}, {"name": "trufocus lio premiere laser indirect ophthalmoscope", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 23 (Reuters) - Iridex Corp:\n* IRIDEX ISSUES VOLUNTARY RECALL OF TRUFOCUS LIO PREMIEREâ„¢ LASER INDIRECT OPHTHALMOSCOPE\n* IRIDEX CORP - REVISED ITS PRELIMINARY FINANCIAL RESULTS FOR Q4 AND FULL YEAR ENDED DECEMBER 30, 2017\n* IRIDEX CORP - RECALLED PRODUCTS WERE MANUFACTURED FROM MAY 26, 2017 TO NOVEMBER 6, 2017 AND DISTRIBUTED FROM JUNE 5, 2017 TO JANUARY 29, 2018\n* IRIDEX CORP - TOTAL REVENUE FOR Q4 OF 2017 IS EXPECTED TO BE $10.2 TO $10.3 MILLION\n* IRIDEX CORP - TOTAL REVENUE FOR 2017 IS EXPECTED TO BE $41.5 TO $41.6 MILLION\n* IRIDEX CORP - COMPANY HAS RECEIVED REPORTS OF THREE ADVERSE EVENTS OCCURRING DURING PROCEDURES IN WHICH TRUFOCUS LIO PREMIERE WAS USED Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-24T05:11:00.000+02:00", "crawled": "2018-02-24T13:37:58.000+02:00", "highlightTitle": ""}